Larimar Therapeutics (LRMR) Other Working Capital Changes (2013 - 2025)
Larimar Therapeutics (LRMR) posted Other Working Capital Changes of -$2.6 million for Q4 2025, down 446.3% on a QoQ basis from $756000.0 in Q3 2025, and down 213.78% year-over-year from $2.3 million in Q4 2024.
Larimar Therapeutics (LRMR) Other Working Capital Changes (2013 - 2025) Analysis & Trends
Larimar Therapeutics' Other Working Capital Changes history runs 13 years deep, the most recent figure standing at -$2.6 million for Q4 2025.
- Quarterly Other Working Capital Changes fell 16.28% year-over-year to -$150000.0 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was -$574000.0 (changed N/A YoY) and the FY2021 annual result came in at -$515000.0, down 20.61% from the prior year.
- Other Working Capital Changes was -$150000.0 for Q3 2022 at Larimar Therapeutics, down from -$146000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at -$123000.0 in Q1 2021 and bottomed at -$150000.0 in Q3 2022.
- A 5-year average of -$7650.0 and a median of $45500.0 in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2021 — Other Working Capital Changes plunged 5781.82% — and 2024, when it jumped 632.52%.
- Larimar Therapeutics' Other Working Capital Changes stood at -$137000.0 in 2021, then dropped by 9.49% to -$150000.0 in 2022.
- Business Quant data shows LRMR's Other Working Capital Changes at -$150000.0 in Q3 2022, -$146000.0 in Q2 2022, and -$141000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.62 Mn |
| Dec 31, 2025 | -2.62 Mn |
| Dec 31, 2025 | -2.62 Mn |
| Sep 30, 2025 | 756,000.00 |
| Sep 30, 2025 | 756,000.00 |
| Sep 30, 2025 | 756,000.00 |
| Jun 30, 2025 | -927,000.00 |
| Jun 30, 2025 | -927,000.00 |
| Jun 30, 2025 | -927,000.00 |
| Mar 31, 2025 | -3.89 Mn |
| Mar 31, 2025 | -3.89 Mn |
| Mar 31, 2025 | -3.89 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 4.48 Mn |
| Sep 30, 2024 | 4.48 Mn |
| Sep 30, 2024 | 4.48 Mn |
| Jun 30, 2024 | 1.41 Mn |
| Jun 30, 2024 | 1.41 Mn |